23:51 , Feb 28, 2017 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Cytomegalovirus (CMV) Studies in cells suggest a bacterial toxin-based inhibitor of US28 could help treat latent CMV infection. In a human monocyte cell line expressing US28, a fusion protein consisting of the US28-binding chemokine...
07:00 , Jul 23, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: CMV CC chemokine receptor (US28)

Infectious disease INDICATION: Cytomegalovirus (CMV) In vitro and mouse studies identified a bacterial toxin-based inhibitor of US28 that could help treat human cytomegalovirus (HCMV) infection. Chemical synthesis and in vitro testing of chemokine-toxin fusion proteins...
08:00 , Jan 17, 2011 |  BioCentury  |  Emerging Company Profile

Inagen: Defense creates offense

The use of immunotoxins to target and kill specific cells has largely been limited to the field of cancer, but Inagen ApS hopes to use a similar approach to target and kill cytomegalovirus-infected cells. Because...